Fivefold Gains From First New Cancer Therapy in Decades
There's big money to be made in treating and curing leukemia. Unfortunately, the AML form of the disease is a tough nut to crack. We haven't seen a new drug approved for the disease in 40 years. We've mainly improved survival through better detection, disease classification and better use of existing drugs. I believe that's going to change.
You Must Be A Subscriber To View This Content.
If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!
Ray Blanco’s FDA Profit Alert
The FDA Profit Alert focuses on medical tech stocks with prices that move based on triggers generally unknown to the market. It is designed to alert you to breakout moves in the medical markets that could ultimately drive huge stock market gains. It’s the single best way to connect the dots that link today’s dynamic, innovative medical market.